Cargando…
CD4-Specific Designed Ankyrin Repeat Proteins Are Novel Potent HIV Entry Inhibitors with Unique Characteristics
Here, we describe the generation of a novel type of HIV entry inhibitor using the recently developed Designed Ankyrin Repeat Protein (DARPin) technology. DARPin proteins specific for human CD4 were selected from a DARPin DNA library using ribosome display. Selected pool members interacted specifical...
Autores principales: | Schweizer, Andreas, Rusert, Peter, Berlinger, Livia, Ruprecht, Claudia R., Mann, Axel, Corthésy, Stéphanie, Turville, Stuart G., Aravantinou, Meropi, Fischer, Marek, Robbiani, Melissa, Amstutz, Patrick, Trkola, Alexandra |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453315/ https://www.ncbi.nlm.nih.gov/pubmed/18654624 http://dx.doi.org/10.1371/journal.ppat.1000109 |
Ejemplares similares
-
P04-40. Dissecting pre- and post-attachment activity of HIV-1 entry inhibitors and neutralizing antibodies
por: Berlinger, L, et al.
Publicado: (2009) -
Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies
por: Abela, Irene A., et al.
Publicado: (2012) -
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
por: Ruprecht, Claudia R., et al.
Publicado: (2011) -
Conformation-dependent recognition of HIV Gp120 by DARPins provides novel possibilities to develop distinct HIV entry inhibitors
por: Mann, AM, et al.
Publicado: (2012) -
P04-37. Kinetic and thermodynamic factors determine HIV-1 neutralizing potency of MPER-specific antibodies
por: Ruprecht, C, et al.
Publicado: (2009)